ZAG/S&W LLP

Photo of

Assisting an Israeli Venture Capital Fund in High-Stakes Arbitration ZAG-S&W represented an Israeli Venture Capital Fund that was the respondent in an ICDR arbitration with its placement agent . . . ›

Photo of

Helping an Israeli Biotech Company Raise Funds in the United States ZAG-S&W assisted client Pluristem Therapeutics Inc. (Nasdaq: PSTI - News) (DAX:PJT) (TASE:PLTR), a clinical stage biotechnology company . . . ›

Photo of

We Have Helped Our Israeli Clients Raise Millions in the United States Our capital markets team has advised on half of the offerings by Israeli companies that listed for the first time on Nasdaq in 2013. ›

Photo of

Building Profile as Go-To Firm for Securities Offerings for Israeli Companies In a busy year for IPOs for Israeli companies, the ZAG-S&W Securities & Corporate Governance Team is focused on listings and offerings for life sciences companies. ›

Photo of

ZAG-S&W Advises Publicly Traded Kibbutz Company on U.S. Acquisition ZAG-S&W advised Plasson Ltd., an Israeli manufacturer of plastic pipe accessories, in its acquisition of a 77 percent interest in . . . ›